Ultrapotent and broad neutralization of SARS-CoV-2 variants by modular, tetravalent, bi-paratopic antibodies is a research paper published in Cell Reports (2022). On theSindex it has a DataRank of 0. It has been cited 14 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: P01AI120943
National Institutes of Health
Grant: R01 AI157155
National Institutes of Health
Grant: R01AI143292
National Institutes of Health
Grant: R01AI161374
Mercatus Center at George Mason University
Grant: 2161
Mercatus Center at George Mason University
Grant: 2189
Ministero dell’Istruzione, dell’Università e della Ricerca
Grant: FISR2020IP_03161
Canadian Institutes of Health Research
Grant: OV3-170649
National Institutes of Health
Grant: 5R01AI161374-02
Development and characterization of engineered therapeutic antibodies against SARS-CoV-2
National Institutes of Health
Grant: 5P01AI120943-03
Structural and Functional Characterization of the Ebola Virus Replication Complex
Canadian Institutes of Health Research
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5R01AI157155-02
Human antibody-based countermeasures against the Coronavirus SARS-CoV-2
National Institutes of Health
Grant: 3R01AI143292-05S1
Novel VP30-host Interactions that Negatively Regulate Ebola Virus Infection
Regione Lazio
Temerty Family Foundation
Canada Foundation for Innovation
Vir Biotechnology
Fondazione Roma
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals